FDA Withdraws Approval Of New Animal Drug Application

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the April 8, 2015, Federal Register, FDA announced that, at the sponsor's request, it is withdrawing approval of a new animal drug application ("NADA") for a fomepizole injectable solution, which is used as an antidote for ethylene glycol poisoning in dogs.
United States Food, Drugs, Healthcare, Life Sciences

In the April 8, 2015, Federal Register,FDA announced that, at the sponsor's request, it is withdrawing approval of a new animal drug application ("NADA") for a fomepizole injectable solution, which is used as an antidote for ethylene glycol poisoning in dogs.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More